ID   OV(hyg)CAR3
AC   CVCL_Y033
SY   Ov(hyg)CAR3
DR   cancercelllines; CVCL_Y033
DR   Wikidata; Q54936876
RX   PubMed=8824553;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_16976; Hygromycin B.
CC   Sequence variation: Mutation; HGNC; HGNC:8979; PIK3R1; Simple; c.1746-2A>T; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C105555; High grade ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0465 ! OVCAR-3
SX   Female
AG   60Y
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 19-12-24; Version: 14
//
RX   PubMed=8824553; DOI=10.1002/(SICI)1097-0215(19960917)67:6<816::AID-IJC10>3.0.CO;2-#;
RA   Mullen, Peter
RA   Ritchie, Alison
RA   Langdon, Simon P.
RA   Miller, William R.
RT   "Effect of Matrigel on the tumorigenicity of human breast and ovarian
RT   carcinoma cell lines.";
RL   Int. J. Cancer 67:816-820(1996).
//